Navigation Links
Conference on cell therapy includes new session on stem cells for non-cardiac organ injury
Date:1/5/2009

WHAT:

The Fifth International Conference on Cell Therapy for Cardiovascular Disease (IC3D) will include a new session on stem cells for non-cardiac organ injury. The session will include new data on stem cells for islet disease and diabetes, bone marrow cells for stroke patients, and treating Parkinson's disease with bone marrow cells.

Highlights from other sessions include the first human data using special bone marrow and adipose cells for heart attack patients and a discussion of the rapid advances in tissue engineering and how surgeons should prepare for this next stage of stem cell therapy.

WHY:

IC3D, one of the largest conferences of its kind with more than 60 internationally recognized faculty members, is a three-day comprehensive program dedicated to the evolving field of cell-based therapies for cardiac repair and regeneration. The theme of this year's meeting is "Cellular and Molecular Building Blocks: Strategies for Cardiovascular Reconstruction in 2009."

The conference encompasses all aspects of cell-based therapeutic approaches to cardiovascular diseases. Research presented at IC3D will touch upon clinical studies of stem cell repair of the heart, brain and peripheral arteries, new sources of adult stem cells and the status of embryonic stem cell research. Each day of the conference will focus on the following diseases and the future role of cell-based therapies.

PROGRAM SPECIFICS:

New sessions for 2009 will include:

  • Major advances in treating peripheral vascular disease
  • Combined cell and tissue regenerative methods
  • Changing the potential of stem cells: Why should we try? How do we do it?
  • New paradigms for the surgeon? How soon will engineered tissue be in the clinic?
  • Discoveries beyond the heart, including the brain and other organs
  • Expanded sessions on Industry Innovations in 2009

The full agenda can be found at:
'/>"/>

Contact: Judy Romero
jromero@crf.org
212-851-9311
Cardiovascular Research Foundation
Source:Eurekalert

Page: 1 2

Related medicine news :

1. Labopharm to host conference call to discuss FDA approval of once-daily RYZOLT(TM) on Tuesday, January 6, 2009 at 8:30 a.m. (ET)
2. Alexion to Present at the 27th Annual JP Morgan Healthcare Conference
3. ViroPharma to Present at the 27th Annual J.P. Morgan Healthcare Conference
4. Inverness Medical Innovations to Participate at JP Morgan Healthcare Conference on January 13, 2009
5. WellPoint to Hold Conference Call and Webcast to Discuss Fourth Quarter Results on January 28, 2009
6. 40 Days for Life Leader to Speak at Personhood Conference
7. Delcath Systems to Host Quarterly Update Conference Call
8. Medco CEO to Present at the 2009 Goldman Sachs Healthcare CEOs Unscripted: A View from the Top Conference
9. Spending Too Much on Healthcare? This Employer-Designed Conference Will Inspire!
10. Hospira to Present at J.P. Morgans 27th Annual Healthcare Conference January 14
11. Abaxis, Inc. to Present at Needham & Companys Eleventh Annual Growth Stock Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/5/2009)NEW ORLEANS, Dec. 5 Leukemia and myeloproliferative disorders are serious and often deadly blood cancers. Research presented today at the 51st Annual Meeting of the American Society of Hematology int
(Date:12/5/2009)Midbrook,s advanced Technology Center helps companies develop and test their cleaning processes. The technology available to the lab allows it to work in a variety of industries and solve problems for
(Date:12/5/2009)Wind Turbines are popping up in the most unusual places, and to do everything from growing mushrooms, making wine to keeping prisoners in jail! , (PRWEB) December 5, 2009 -- W
(Date:12/4/2009)NEW YORK, Dec. 4 Thousands of KPMG LLP employees came together in more than 90 offices nationwide today, to participate in a community service event which combines the audit, tax and advisory firm,s
(Date:12/4/2009)WASHINGTON, Dec. 4 The American Association of Homes and Services for the Aging (AAHSA) applauds the Senate for ensuring that the Community Living and Supportive Services (CLASS) provisions remain i
Breaking Medicine News(10 mins):Health News:Advances in Genetic Understanding and Treatment Protocols Lead to Significant Progress in Leukemia and Myeloproliferative Disorders 2Health News:Advances in Genetic Understanding and Treatment Protocols Lead to Significant Progress in Leukemia and Myeloproliferative Disorders 3Health News:Advances in Genetic Understanding and Treatment Protocols Lead to Significant Progress in Leukemia and Myeloproliferative Disorders 4Health News:Advances in Genetic Understanding and Treatment Protocols Lead to Significant Progress in Leukemia and Myeloproliferative Disorders 5Health News:Advances in Genetic Understanding and Treatment Protocols Lead to Significant Progress in Leukemia and Myeloproliferative Disorders 6Health News:Advances in Genetic Understanding and Treatment Protocols Lead to Significant Progress in Leukemia and Myeloproliferative Disorders 7Health News:Advances in Genetic Understanding and Treatment Protocols Lead to Significant Progress in Leukemia and Myeloproliferative Disorders 8Health News:Advances in Genetic Understanding and Treatment Protocols Lead to Significant Progress in Leukemia and Myeloproliferative Disorders 9Health News:Midbrook Lab Testing Provides Results for Cleaning Process Develop and Verification 2Health News:Midbrook Lab Testing Provides Results for Cleaning Process Develop and Verification 3Health News:Distributor Announces New Applications for Wind Turbines 2Health News:Distributor Announces New Applications for Wind Turbines 3Health News:KPMG Employees Provide 'Holiday Bear Hugs' and Books in Firmwide Service Day for Children 2
...procedures are generally being fleased from patien...ne of California, observed a study at present whic...sary fertility procedures.// Lawrence Werlin,...gnosis (PGD) for three distinct groups of women. P...
...n pointed at reducing carbon monoxide emissions ha...onoxide can be fatal if inhaled and is involved in...ear. //The main sources of carbon monoxide are veh...talytic converters in cars helps bring down the ca...
...to researchers, it may be possible to increase the...shortage of organs for transplantation.// Research...ng at the supply of lungs for transplant. They not...hecked 30 pairs of lungs that had been rejected fo...
...to researchers in England, a baby's birth weight i...late adulthood. The study also shows women with th...risk of developing diabetes.// More than 4,10...ing among those with the highest insulin resistanc...
...rs at the Colulmbia University found that eating m...eloping Alzheimer's disease in some people. Previo...ricted diet tend to live longer. //Researchers fee...lso damage cells and may increase the damage done ...
...antioxidants have always been beneficial to our bo...tent is released from the grain, and thereby makin...e has always been a common misconception that boil...ou may well gain more antioxidant power than you l...
Other Medicine News:Health News:Diet combined to Alzheimer's disease 2
(Date:12/4/2009)FREMONT, Calif., Dec. 4 Vermillion, Inc. (VRML) (Pink Sheets: VRMLQ) announced that on December 3, 2009, it filed its First Amended Plan of Reorganization and related amended Disclosure Statement wit
(Date:12/4/2009)OMAHA, Neb., Dec. 4 Amber Pharmacy announced today that it received accreditation by the Accreditation Commission for Health Care, Inc. (ACHC) for specialized pharmacy services. For nearly 15 years,
(Date:12/4/2009)DURHAM, N.C., Dec. 4 Oxygen Biotherapeutics, Inc. (OTC Bulletin Board: OXBT) today announced that the first patient has been enrolled in the company,s Phase II-b, dose escalation, clinical trial in S
Breaking Medicine Technology:Vermillion Files Amended Plan of Reorganization and Exchanges Debt 2Vermillion Files Amended Plan of Reorganization and Exchanges Debt 3Amber Pharmacy Earns Accreditation From ACHC 2Oxygen Biotherapeutics, Inc. Enrolls First Patient in Traumatic Brain Injury Clinical Trial in Switzerland 2Judge Halts IHSS Home Care Cuts 3B Says They Likely Violate Federal Law 59781 1Judge Halts IHSS Home Care Cuts 3B Says They Likely Violate Federal Law 59781 2Narconon of Georgia Applauds Efforts of Prescription Buy Back Programs 5577 1Narconon of Georgia Applauds Efforts of Prescription Buy Back Programs 5577 2Researcher honored for experimental work in nanotechnology 14533 1Researcher honored for experimental work in nanotechnology 14533 2
... April 11, 2007 (PRIME NEWSWIRE) --,Hana Bioscienc...sed,on advancing cancer care, will present preclin...ion at the American Association,for Cancer Researc...geles, California. , Abstract No. 2210: "Combining...mall cell lung cancer (NSCLC) athymic nude,mice xe...
...onex Inc. (TSX:LPX), a,biopharmaceutical company s...d to High Density Lipoprotein (HDL), often called,...om further,analysis of the Phase I/II Clinical Tri...ped for the treatment of dyslipidemia and,heart di...indicated that all,blood chemistry and blood press...
Other Medicine Technology:Hana Biosciences Announces Data to be Presented On Talvesta,(Talotrexin) for Injection at The American Association for Cancer,Research Annual Meeting 2Hana Biosciences Announces Data to be Presented On Talvesta,(Talotrexin) for Injection at The American Association for Cancer,Research Annual Meeting 3Liponex Inc. Reports Further Analysis of CRD5 Phase I/II Clinical,Trial Data 2Liponex Inc. Reports Further Analysis of CRD5 Phase I/II Clinical,Trial Data 3
... Clear Plus™ Uncuffed Endotracheal Tube w. F...et inside. Sterile, Single use. A quality Rusch en... is ready to use saving you time and storage space...ate smooth withdrawal. It is designed with a soft ...
Slick Set® Uncuffed
Cuffed Nasoral Magill
...ubber tube with Murphy eye. Laser resistant foam s...uffs (One inside other) 40cm (16") long, Single Us...access and optimum visibility within the operating...he tube shaft has a special laser-guard of approx....
Medicine Products: